APA (7th ed.) Citation

GJ, H., DL, B., & JR, B. (1974). Phase I-II evaluation of weekly mitomycin-C (NSC-26980) for patients with metastatic GI and breast malignancies. Oncology, 30(3), 236. https://doi.org/10.1159/000224961

Chicago Style (17th ed.) Citation

GJ, Hum, Bogdon DL, and Bateman JR. "Phase I-II Evaluation of Weekly Mitomycin-C (NSC-26980) for Patients with Metastatic GI and Breast Malignancies." Oncology 30, no. 3 (1974): 236. https://doi.org/10.1159/000224961.

MLA (9th ed.) Citation

GJ, Hum, et al. "Phase I-II Evaluation of Weekly Mitomycin-C (NSC-26980) for Patients with Metastatic GI and Breast Malignancies." Oncology, vol. 30, no. 3, 1974, p. 236, https://doi.org/10.1159/000224961.